Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers
An Open Prospective Clinical Study on Safety and Efficacy of Surgical Treatment of Patients With Anterior Urethral Stricture Using a Tissue-engineered Construct Based on Autologous Buccal Mucosa Cells and Matrix From Reconstituted Collagen and Reinforcing Polylactoglycolide Fibers
Sponsor: I.M. Sechenov First Moscow State Medical University
Listed as NCT03205670, this EARLY_PHASE1 trial focuses on Urethral Stricture and remains ongoing. Sponsored by I.M. Sechenov First Moscow State Medical University, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown EARLY_PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Enrolling By Invitation EARLY_PHASE1
▶ Show 4 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Enrolling By Invitation EARLY_PHASE1
-
Sep 2018 — Mar 2020 [monthly]
Enrolling By Invitation EARLY_PHASE1
Status: Recruiting → Enrolling By Invitation
-
Jun 2018 — Sep 2018 [monthly]
Recruiting EARLY_PHASE1
-
Aug 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- I.M. Sechenov First Moscow State Medical University
For direct contact, visit the study record on ClinicalTrials.gov .